KB-109

N/A

Report date: 2023/01/15 23:06:56
NME

Base Information

Drug NameKB-109
Drug Alias NameKB-109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulatorsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesKaleido Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesKaleido Biosciences Inc
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A